July 6, 2020 / 10:21 AM / a month ago

BRIEF-Mylan Secures Regulatory Approval For Remdesivir Lyophilized Powder For Injection 100 Mg/Vial In India

July 6 (Reuters) - Mylan NV:

* MYLAN SECURES REGULATORY APPROVAL FOR REMDESIVIR LYOPHILIZED POWDER FOR INJECTION 100 MG/VIAL IN INDIA FOR RESTRICTED EMERGENCY USE IN COVID-19 PATIENTS

* MYLAN NV - DRUG WILL BE LAUNCHED UNDER BRAND NAME DESREM™ IN INDIA

* MYLAN NV - DRUG WILL WILL BE AVAILABLE TO PATIENTS IN JULY AT A PRICE OF INR 4,800

* MYLAN NV - MYLAN WILL MANUFACTURE REMDESIVIR IN INDIA AT ITS INJECTABLES FACILITIES

* MYLAN NV - DRUG IS APPROVED FOR TREATMENT OF SUSPECTED OR LABORATORY CONFIRMED INCIDENCES OF COVID-19 IN ADULTS AND CHILDREN Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below